Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways

Pulmonary arterial hypertension (PAH) is a chronic and progressive disorder characterized by vascular remodeling of the small pulmonary arteries, resulting in elevated pulmonary vascular resistance and ultimately, right ventricular failure. Expanded understanding of PAH pathophysiology as it pertain...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cardiovasc Pharmacol Ther
Egile Nagusiak: Mandras, Stacy, Kovacs, Gabor, Olschewski, Horst, Broderick, Meredith, Nelsen, Andrew, Shen, Eric, Champion, Hunter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2021
Gaiak:
Review Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8261771/
https://ncbi.nlm.nih.gov/pubmed/33836637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/10742484211006531
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak